Alzex Neuropharma Inc. (TRRI)
OTCMKTS · Delayed Price · Currency is USD
0.0002
-0.0001 (-33.33%)
At close: Dec 30, 2025
Alzex Neuropharma Market Cap
Alzex Neuropharma has a market cap or net worth of $301 as of January 23, 2026. Its market cap has decreased by -99.95% in one year.
Market Cap
301.00
Enterprise Value
n/a
Revenue
4.73M
Ranking
n/a
PE Ratio
0.01
Stock Price
$0.00
Market Cap Chart
Since July 14, 2008, Alzex Neuropharma's market cap has decreased from 60.00K to 301.00, a decrease of -99.50%. That is a compound annual growth rate of -26.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 301.00 | -99.90% |
| Dec 31, 2024 | 298.04K | -1.00% |
| Dec 14, 2023 | 301.05K | -9.09% |
| Dec 23, 2022 | 331.16K | -51.11% |
| Dec 28, 2021 | 677.37K | 857,331.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlobeImmune | 575.00 |
| Tetra Bio-Pharma | 516.00 |
| RegeneRx Biopharmaceuticals | 453.00 |
| Eloxx Pharmaceuticals | 330.00 |
| Nabriva Therapeutics | 323.00 |
| Predictive Technology Group | 317.00 |
| Spencer Pharmaceutical | 271.00 |
| Nanobac Pharmaceuticals | 250.00 |